litlas
Log inCreate account

Michael L. Blute

Active 1986–2024

Also published as
MICHAEL L. BLUTE
198
Papers
45,783
Citations
120
h-index
197
i10-index

Citations

Citations per year for Michael L. Blute1931: 2 citations1984: 1 citations1988: 4 citations1989: 6 citations1990: 4 citations1991: 13 citations1992: 8 citations1993: 22 citations1994: 27 citations1995: 11 citations1996: 34 citations1997: 65 citations1998: 81 citations1999: 111 citations2000: 148 citations2001: 158 citations2002: 174 citations2003: 267 citations2004: 298 citations2005: 344 citations2006: 369 citations2007: 437 citations2008: 456 citations2009: 414 citations2010: 393 citations2011: 444 citations2012: 453 citations2013: 366 citations2014: 327 citations2015: 368 citations2016: 319 citations2017: 260 citations2018: 240 citations2019: 811 citations2020: 714 citations2021: 541 citations2022: 347 citations2023: 264 citations2024: 414 citations2025: 144 citations2026: 4 citations1932–1983: no citations, so these years are not shown1985–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,534 citing papers, 33.2% of this breakdownChina: 805 citing papers, 7.6% of this breakdownItaly: 691 citing papers, 6.5% of this breakdownGermany: 640 citing papers, 6% of this breakdownUnited Kingdom: 513 citing papers, 4.8% of this breakdownCanada: 486 citing papers, 4.6% of this breakdownFrance: 437 citing papers, 4.1% of this breakdownJapan: 342 citing papers, 3.2% of this breakdownNetherlands: 307 citing papers, 2.9% of this breakdownAustralia: 225 citing papers, 2.1% of this breakdownSpain: 219 citing papers, 2.1% of this breakdownAustria: 193 citing papers, 1.8% of this breakdown
0%33.2%Other 21.1%

Institutions

Fields

  • Medicine85%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Immunology and Microbiology2.6%
  • Engineering0.8%
  • Computer Science0.7%
  • Chemistry0.2%
  • Other1.1%

Topics

  • Renal cell carcinoma treatment11.4%
  • Prostate Cancer Treatment and Research8.3%
  • Prostate Cancer Diagnosis and Treatment7.8%
  • Bladder and Urothelial Cancer Treatments5.6%
  • Cancer Immunotherapy and Biomarkers5.1%
  • Renal and related cancers3.7%
  • Other58.1%

Coauthors

All papers

Open in search
  1. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

    Authors: David G. Bostwick, Anna Pacelli, Michael L. Blute, Patrick C. Roche, Gerald P. Murphy - Cancer 1998 cited by 702

  2. Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

    Authors: Bradley C. Leibovich, Christine M. Lohse, Paul L. Crispen, Stephen A. Boorjian, R. Houston Thompson, Michael L. Blute, John C. Cheville - The Journal of Urology 2010 cited by 460

  3. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

    Authors: Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Christine M. Lohse, Igor Frank, Eugene D. Kwon, Amy L. Weaver, Alexander S. Parker, Horst Zincke - Cancer 2003 cited by 831

  4. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Authors: Michael L. Blute, Bradley C. Leibovich, Christine M. Lohse, John C. Cheville, Horst Zincke - British Journal of Urology 2004 cited by 697

  5. Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

    Authors: Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, R. Houston Thompson, Stephen A. Boorjian, Haidong Dong, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon - Clinical Cancer Research 2008 cited by 272

  6. Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma

    Authors: Xavier Frigola, Brant A. Inman, Christine M. Lohse, Christopher J. Krco, John C. Cheville, R. Houston Thompson, Bradley C. Leibovich, Michael L. Blute, Haidong Dong, Eugene D. Kwon - Clinical Cancer Research 2011 cited by 356

  7. An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score

    Authors: Igor Frank, Michael L. Blute, John C. Cheville, Christine M. Lohse, Amy L. Weaver, Horst Zincke - The Journal of Urology 2002 cited by 1,138

  8. Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy

    Authors: R. Houston Thompson, Brian R. Lane, Christine M. Lohse, Bradley C. Leibovich, Amr Fergany, Igor Frank, Inderbir S. Gill, Michael L. Blute, Steven C. Campbell - European Urology 2010 cited by 763

  9. Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma

    Authors: John C. Cheville, Christine M. Lohse, Horst Zincke, Amy L. Weaver, Michael L. Blute - The American Journal of Surgical Pathology 2003 cited by 1,091

  10. Sarcomatoid Renal Cell Carcinoma

    Authors: John C. Cheville, Christine M. Lohse, Horst Zincke, Amy L. Weaver, Bradley C. Leibovich, Igor Frank, Michael L. Blute - The American Journal of Surgical Pathology 2004 cited by 416

  11. Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

    Authors: Igor Frank, Michael L. Blute, John C. Cheville, Christine M. Lohse, Amy L. Weaver, Horst Zincke - The Journal of Urology 2003 cited by 1,074

  12. Guideline for Management of the Clinical T1 Renal Mass

    Authors: Steven C. Campbell, Andrew C. Novick, Arie S. Belldegrun, Michael L. Blute, George K. Chow, Ithaar Derweesh, Martha M. Faraday, Jihad Kaouk, Raymond J. Leveillee, Surena F. Matin, Paul Russo, Robert G. Uzzo - The Journal of Urology 2009 cited by 1,841

  13. Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors

    Authors: Inderbir S. Gill, Louis R. Kavoussi, Brian R. Lane, Michael L. Blute, Denise C. Babineau, José R. Colombo, Igor Frank, Sompol Permpongkosol, Christopher Weight, Jihad Kaouk, Michael W. Kattan, Andrew C. Novick - The Journal of Urology 2007 cited by 1,201

  14. Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

    Authors: R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich, Haidong Dong, Christine M. Lohse, W. Scott Webster, Shomik Sengupta, Igor Frank, Alexander S. Parker, Horst Zincke, Michael L. Blute, Thomas J. Sebo, John C. Cheville, Eugene D. Kwon - Cancer Research 2006 cited by 870

  15. PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    Authors: R. Houston Thompson, Haidong Dong, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Eugene D. Kwon - Clinical Cancer Research 2007 cited by 567

  16. Robotic-assisted laparoscopic partial nephrectomy: Technique and initial clinical experience with da Vinci robotic system

    Authors: Matthew T. Gettman, Michael L. Blute, George K. Chow, Richard Neururer, Georg Bartsch, Reinhard Peschel - Urology 2004 cited by 462

  17. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

    Authors: R. Houston Thompson, Michael D. Gillett, John C. Cheville, Christine M. Lohse, Haidong Dong, W. Scott Webster, Kent G. Krejci, John R. Lobo, Shomik Sengupta, Lieping Chen, Horst Zincke, Michael L. Blute, Scott E. Strome, Bradley C. Leibovich, Eugene D. Kwon - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 766

  18. Pelvic Lymph Node Dissection in Prostate Cancer

    Authors: Alberto Briganti, Michael L. Blute, James H. Eastham, Markus Graefen, Axel Heidenreich, Jeffrey Karnes, Francesco Montorsi, Urs E. Studer - European Urology 2009 cited by 506

  19. Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature

    Authors: Alessandro Volpe, Michael L. Blute, Vincenzo Ficarra, Inderbir S. Gill, Alexander Kutikov, F. Porpiglia, Craig Rogers, Karim Touijer, Hendrik Van Poppel, R. Houston Thompson - European Urology 2015 cited by 350

  20. Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence

    Authors: Stephen A. Boorjian, R. Houston Thompson, Matthew K. Tollefson, Laureano J. Rangel, Eric J. Bergstralh, Michael L. Blute, R. Jeffrey Karnes - European Urology 2011 cited by 329

  21. B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy

    Authors: Timothy J. Roth, Yuri Sheinin, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, Brant A. Inman, Amy E. Krambeck, Maureen E. Mckenney, R. Jeffrey Karnes, Michael L. Blute, John C. Cheville, Thomas J. Sebo, Eugene D. Kwon - Cancer Research 2007 cited by 269

  22. Survival after complete surgical resection of multiple metastases from renal cell carcinoma

    Authors: Angela L. Alt, Stephen A. Boorjian, Christine M. Lohse, Brian A. Costello, Bradley C. Leibovich, Michael L. Blute - Cancer 2011 cited by 430

  23. Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy

    Authors: Richard Ashley, Brant A. Inman, Thomas J. Sebo, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon, Horst Zincke - Cancer 2006 cited by 335

  24. Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma

    Authors: Sameer Siddiqui, Xavier Frigola, Sandra Bonne-Année, Maria Mercader, Susan M. Kuntz, Amy E. Krambeck, Shomik Sengupta, Haidong Dong, John C. Cheville, Christine M. Lohse, Christopher J. Krco, W. Scott Webster, Bradley C. Leibovich, Michael L. Blute, Keith L. Knutson, Eugene D. Kwon - Clinical Cancer Research 2007 cited by 201